ESSA Pharma/$EPIX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ESSA Pharma
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
Ticker
$EPIX
Sector
Primary listing
Industry
Biotechnology
Headquarters
Vancouver, Canada
Employees
35
Website
ESSA Pharma Metrics
BasicAdvanced
$83M
-
-$0.64
1.58
-
Price and volume
Market cap
$83M
Beta
1.58
52-week high
$6.90
52-week low
$1.40
Average daily volume
339K
Financial strength
Current ratio
67.168
Quick ratio
66.655
Long term debt to equity
0.136
Total debt to equity
0.247
Profitability
Management effectiveness
Return on assets (TTM)
-16.48%
Return on equity (TTM)
-23.07%
Valuation
Price to book
0.73
Price to tangible book (TTM)
0.73
Price to free cash flow (TTM)
-3.72
Free cash flow yield (TTM)
-26.88%
Free cash flow per share (TTM)
-0.505
Growth
Earnings per share change (TTM)
2.19%
3-year earnings per share growth (CAGR)
-9.49%
10-year earnings per share growth (CAGR)
-21.88%
What the Analysts think about ESSA Pharma
Analyst ratings (Buy, Hold, Sell) for ESSA Pharma stock.
ESSA Pharma Financial Performance
Revenues and expenses
ESSA Pharma Earnings Performance
Company profitability
ESSA Pharma News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ESSA Pharma stock?
ESSA Pharma (EPIX) has a market cap of $83M as of August 01, 2025.
What is the P/E ratio for ESSA Pharma stock?
The price to earnings (P/E) ratio for ESSA Pharma (EPIX) stock is 0 as of August 01, 2025.
Does ESSA Pharma stock pay dividends?
No, ESSA Pharma (EPIX) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next ESSA Pharma dividend payment date?
ESSA Pharma (EPIX) stock does not pay dividends to its shareholders.
What is the beta indicator for ESSA Pharma?
ESSA Pharma (EPIX) has a beta rating of 1.58. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.